• Subscribe
    e

    Xconomy’s Digital Events →

    ▾
  • Xconomy National

  • Our
    Regions
    • National ›
      • Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
        Sanofi, Pfizer & Bristol Drugs Among the 12 Approvals to Look Out for in Q4
      View More in National ›
    • Europe ›
      • FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
        FDA Panel Vote Weighs in Favor of Alkermes Psych Drug, With Caveats
      View More in Europe ›
    • Boston ›
      • Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
        Vertex Stops Test of Rare Disease Drug, Dimming Pipeline Prospects
      View More in Boston ›
    • Boulder/Denver ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Indiana ›
    • New York ›
      • “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
        “Opioid Stacking” Concerns Lead FDA to Reject Avenue Therapeutics Drug
      View More in New York ›
    • Philadelphia ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Philadelphia ›
    • Raleigh-Durham ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Raleigh-Durham ›
    • San Diego ›
      • Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
        Despite Phase 2 Failure, Gossamer Bio Sees a Path for Drug in Asthma
      View More in San Diego ›
    • San Francisco ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in San Francisco ›
    • Seattle ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Seattle ›
    • Texas ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Texas ›
    • Wisconsin ›
      • BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
        BIO Launches 'Biotech Votes' Campaign to Encourage Registration and Informed Voting
      View More in Wisconsin ›
  • Topic
    Channels
    • Life Sciences›
        View More in Life Sciences ›
      • Healthtech›
          View More in Healthtech ›
        • Robotics and A.I.›
            View More in Robotics and A.I. ›
          • Startups›
              View More in Startups ›
          • Our
            Events
            • All Xconomy Events ›
          • Xconomy
            Insight

          “jim-blair” Archives

          in
          Entry Author Date Location
          BioNano Raises $53M to Identify “Structural Variations” in Genome Bruce V. Bigelow 11/20/14 San Diego
          Which VCs Are Poised to Profit From the Biotech IPO Boom? Luke Timmerman 09/09/13 National
          Connect Bestows ‘Hall of Fame’ Award on Hybritech Founder Ted Greene Bruce V. Bigelow 03/05/12 San Diego
          Applied Proteomics, Co-Founded by Danny Hillis, Gets New CEO, $22.5M Bruce V. Bigelow 02/07/12 San Diego
          Never Back Smug: A Lesson for Life Sciences From Newt Gingrich Luke Timmerman 01/30/12 National
          CoDa Therapeutics Adds $19M Round, Led by Domain, to Pursue Diabetes Complication Luke Timmerman 04/18/11 San Diego
          ATyr Pharma Pockets $23M to Create New Class of Protein Drugs, and New Targets Luke Timmerman 10/26/10 San Diego
          San Diego’s Zogenix Moving Fast to Commercialize Drug-and-Device Combo Bruce V. Bigelow 08/17/10 San Diego
          Avalon Stakes Claim as Survivor Among San Diego Biotech VCs Luke Timmerman 04/12/10 San Diego
          Page 1 of 1

          Underwriters and Partners

          Xconomy Insight
          • Potency Assay Development for Cell and Gene Therapy Products

            Sponsored · Whitepaper

            Potency Assay Development for Cell and Gene Therapy Products

            Create well-controlled, biologically relevant test systems and validate them to support FDA approvals

            Absorption Systems
          • Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Sponsored · Webinar

            Sept. 15 – Challenges of Implementing Innovation in Drug Discovery & Development

            Phenotypic Screening & Profiling to Understand a Compound's Disease Impact

            Eurofins Discovery
          • Decentralized Clinical Trials: The Call for a New Paradigm

            Sponsored · Whitepaper

            Decentralized Clinical Trials: The Call for a New Paradigm

            Virtual/hybrid trials and decentralized research can better integrate healthcare into patients’ lives and accelerate approval of new medications

            PRA Health Sciences

          Xconomy on Demand

          We offer a number of ways to subscribe for free!

          Subscribe Now
          Informa Connect Logo Informa Connect Logo
          • Home
          • Privacy Policy
          • Security Disclosures
          • About
          • Contact Us
          • Archives
          • Advertise
          • Subscribe for Free

          © 2007-2021, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.